Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities    
Net loss $ (56,831) $ (55,486)
Adjustments to reconcile net loss to net cash used in operating activities    
Gain on remeasurement of private warrants (7,007) 21,957
Share-based compensation 27,983 20,696
Depreciation and amortization 8,588 4,311
Inventory reserves 597
Deferred income taxes (531)
Loss on write-off of deferred loan costs 1,900
Amortization of debt issuance costs and debt discounts 1,152 207
Gain on forgiveness of debt (1,776)
Amortization of right-of-use assets and lease liability (173) (806)
Contract asset reserve 1,216
Other 872 66
Changes in operating assets and liabilities, net of effects of aquisitions:    
Accounts receivable, net (2,166) (3,229)
Other receivables 2,692 (235)
Inventories (10,838) (4,011)
Prepaid expenses and other current assets 1,434 (1,520)
Contract assets (1,540) (1,552)
Other assets (5) 40
Accounts payable (2,693) 1,967
Accrued and other long-term liabilities (2,220) (3,537)
Unearned revenue and contract liabilities 2,077 (1,633)
Net cash used in operating activities (37,393) (22,641)
Cash flows from investing activities    
Purchases of property, plant and equipment (108,850) (51,906)
Acquisition of Novomer, net of cash acquired (14)
Proceeds from sales of property, plant and equipment 55 340
Net cash used in investing activities (108,809) (51,566)
Cash flows from financing activities    
Proceeds from exercise of warrants, net of issuance costs 138,202
Proceeds from long-term debt 169
Cash paid for debt issuance costs (279) (1,684)
Proceeds from exercise of stock options 197 2,375
Proceeds from employee stock purchase plan 296 92
Principal payments on long-term debt (88) (27,075)
Cost related to warrants (55)
Proceeds from issuance of common stock, net of issuance costs (890)
Net cash provided by financing activities 71 111,189
Net (decrease) increase in cash and cash equivalents and restricted cash (146,131) 36,982
Cash and cash equivalents and restricted cash    
Cash and cash equivalents and restricted cash-beginning of period 286,968 379,897
Cash and cash equivalents and restricted cash-end of period 140,837 416,879
Supplemental Cash Flow Information [Abstract]    
Cash paid for interest, net of interest capitalized 481 242
Cash paid for operating leases 1,771 1,589
Inventory consumed in constructing property, plant and equipment 2,084
Changes in accounts payable and accrued liabilities related to purchase of PP&E $ (11,797) $ 5,983